PIMCO Mortgage Opportunities and Bd I-3 (PMZNX)
Nasdaq • Currently unchanged in today's trading session
1 member of Congress has disclosed 1 trade in PIMCO Mortgage Opportunities and Bd I-3 (PMZNX) via STOCK Act filings. The most recent disclosure was a purchase by Rashida Tlaib on 29 May 2025. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).
PIMCO Mortgage Opportunities and Bd I-3 is currently trading at $9.21, positioned at 15% of its 52-week range ($9.16 – $9.50).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
PIMCO Mortgage Opportunities and Bd I-3 Price History and Technical Analysis
Congressional Trading Activity for PMZNX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about PMZNX
- Which members of Congress have traded PMZNX?
- 1 member of Congress has disclosed 1 trade in PIMCO Mortgage Opportunities and Bd I-3 (PMZNX) under the STOCK Act: Rashida Tlaib.
- When was PMZNX most recently disclosed by Congress?
- The most recent PMZNX disclosure was a purchase by Rashida Tlaib on 29 May 2025.
- What is the total disclosed congressional trading volume for PMZNX?
- Members of Congress have disclosed approximately $8K in PMZNX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in PMZNX?
- This PMZNX page updates as soon as new STOCK Act disclosures are filed for PIMCO Mortgage Opportunities and Bd I-3. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track PMZNX in Congress
See when politicians buy or sell this stock